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The Saccharomyces cerevisiae kinase Ste20 is a member of the p21-activated kinase (PAK) family with several
functions, including pheromone-responsive signal transduction. While PAKs are usually activated by small G
proteins and Ste20 binds Cdc42, the role of Cdc42-Ste20 binding has been controversial, largely because Ste20
lacking its entire Cdc42-binding (CRIB) domain retains kinase activity and pheromone response. Here we
show that, unlike CRIB deletion, point mutations in the Ste20 CRIB domain that disrupt Cdc42 binding also
disrupt pheromone signaling. We also found that Ste20 kinase activity is stimulated by GTP-bound Cdc42 in
vivo and this effect is blocked by the CRIB point mutations. Moreover, the Ste20 CRIB and kinase domains
bind each other, and mutations that disrupt this interaction cause hyperactive kinase activity and bypass the
requirement for Cdc42 binding. These observations demonstrate that the Ste20 CRIB domain is autoinhibitory
and that this negative effect is antagonized by Cdc42 to promote Ste20 kinase activity and signaling. Parallel
results were observed for filamentation pathway signaling, suggesting that the requirement for Cdc42-Ste20
interaction is not qualitatively different between the mating and filamentation pathways. While necessary for
pheromone signaling, the role of the Cdc42-Ste20 interaction does not require regulation by pheromone or the
pheromone-activated G complex, because the CRIB point mutations also disrupt signaling by activated
forms of the kinase cascade scaffold protein Ste5. In total, our observations indicate that Cdc42 converts Ste20
to an active form, while pathway stimuli regulate the ability of this active Ste20 to trigger signaling through a
particular pathway.
The Saccharomyces cerevisiae protein Ste20 is the founding
member of the p21-activated kinase (PAK) family of protein
kinases. It was originally identified for its signaling role in the
yeast mating pathway (2, 26, 49), though subsequently it has
been found to function in other signaling pathways that regu-
late filamentous growth and osmotic stress response (31, 43,
48, 51), as well as in the control of actin organization and
polarized growth (13, 16, 22, 55, 63). In the mating pathway,
Ste20 mediates activation of a mitogen-activated protein
(MAP) kinase cascade in response to extracellular mating
pheromones (reviewed in references 15, 17, and 20). These
pheromones bind to G protein-coupled receptors and trigger
release of G dimers, which activate the MAP kinase cascade
in a manner involving recruitment of the kinase cascade scaf-
fold protein Ste5 to the plasma membrane (18, 36, 47, 62). This
is thought to bring the Ste5-associated kinase Ste11 (a MAP
kinase kinase kinase) into close proximity with Ste20, which
phosphorylates and activates Ste11 (60, 65). Ste20 is enriched
at the cell periphery in both growing and mating cells via
interaction with the membrane-bound GTPase Cdc42 (27, 39,
45, 47, 64). In addition, Ste20 binds the pheromone-activated
G complex (29), potentially endowing Ste20 with increased
kinase activity, increased access to Ste11, or both.
PAKs are commonly activated by small GTPases of the
Cdc42/Rac family (4, 14). While Ste20 binds the GTPase
Cdc42, there have been conflicting reports regarding the role
of this interaction in mating pathway signaling. Early studies
suggested that Cdc42 and its guanine nucleotide exchange fac-
tor Cdc24 were required for pheromone response (58, 67) and
that GTP-bound Cdc42 could stimulate Ste20 kinase activity in
vitro (58). Later studies suggested that the apparent require-
ment for Cdc24 and Cdc42 in pheromone response was an
artifact of using conditional mutants that arrest at a nonre-
sponsive position in the cell cycle (42). Furthermore, other
studies concluded that while Cdc42 binding was required for
proper localization of Ste20 and for its role in the filamentation
and osmotic response pathways (27, 45, 48), it was not required
for Ste20 kinase activity or for its role in pheromone response
(27, 45). In these latter studies, the role of the Cdc42-Ste20
interaction was tested by removal of the entire Cdc42/Rac
interaction binding (CRIB) domain from Ste20.
Recent studies of other PAK family members have sug-
gested that these kinases are frequently regulated by an auto-
inhibitory mechanism that involves the CRIB domain. For
some members of this family, including human PAK1/-PAK
and Schizosaccharomyces pombe Pak1/Shk1, it has been ob-
served that the CRIB domain can bind to and inhibit the
kinase domain (21), which has been confirmed recently for
human PAK1 by crystallography (30). Furthermore, mutations
in either domain that disrupt this intramolecular binding can
lead to kinase activation (9, 59, 66, 68). In accord with this
regulatory mechanism, recent mutational studies of yeast
Cdc42 have reasserted its involvement in activating Ste20 for
pheromone signaling, because mutant forms of Cdc42 that are
impaired for binding Ste20 show defects in pheromone re-
sponse, and these defects can be rescued by deletion of the
Ste20 CRIB domain (39).
In this study, we have reinvestigated the role of the Ste20
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CRIB domain in mediating Cdc42 binding and pheromone-
responsive signaling. Our results indicate that Ste20 kinase
activity and signaling are limited by inhibitory binding between
the CRIB and kinase domains. They further suggest that bind-
ing of Cdc42 to the Ste20 CRIB domain activates the kinase
activity and signaling ability of Ste20 and that this step is
required for G-mediated signaling but is not itself regulated
by G. Removal of inhibitory CRIB residues or of the CRIB
domain in its entirety allows Cdc42-independent kinase activity
and signaling ability, indicating that Ste20 adheres to the gen-
eral model for PAK family kinases in which they are activated
by small GTPases through relief of autoinhibition.
MATERIALS AND METHODS
Yeast strains. Yeast strains are listed in Table 1. All two-hybrid assays were
performed using strain PPY760 (11), a derivative of strain L40 (5). Filamentation
assays used strains in the 1278b background, generated by crosses involving
strains L5585 (51), L6149 (53), and meiotic segregants of strain L5978 (35).
KBY211 (22) was described previously, as were PPY496, PPY640, PPY866, and
PT2 (47). PPY913 was derived from YEL206 (27) by integration of a LEU2-
marked FUS1-lacZ reporter at the FUS1 locus, using SphI-digested pFC23 (46).
Replacement of the genomic STE20 locus with the S338A/H345G or 334–369
allele used a pop-in/pop-out strategy, in which cells were first transformed with
BamHI-digested pPP1042 or pPP1043, respectively, and selected for uracil pro-
totrophy, and then spontaneous 5-fluoro-orotic acid-resistant clones were
screened by PCR (followed by restriction digests) to determine which allele was
retained. By this method, PPY1203 and PPY1205 were derived from PPY640,
and PPY1200 and PPY1202 were derived from PPY966.
To tag the Ste20 C terminus with 12 tandem copies of the Myc epitope, a
tagging cassette was inserted at the genomic STE20 locus by transformation with
HindIII-digested pGSMste20::12myc (a gift from J. Moskow and D. Lew), se-
lection for uracil prototrophy, and screening by immunoblotting using anti-Myc
antibodies for an appropriate-sized product. By this method, strains PPY1234,
PPY1236, and PPY1238 were derived from PPY640, PPY1203, and PPY1205,
respectively.
Plasmids. Plasmids used in this study are listed in Table 2. Signaling properties
of Ste20 mutants were mostly studied in two parental constructs, pRL116 and
pPP1001. pRL116 (27) is a CEN URA3 plasmid expressing a green fluorescent
protein GFP(S65T)-STE20 fusion gene from the native STE20 promoter; it
includes native STE20 sequences 480 bp upstream and 30 bp downstream of the
open reading frame. pPP1001 (Table 2) is a CEN URA3 plasmid expressing the
native, unfused STE20 gene from its own promoter; it includes native STE20
sequences 1,210 bp upstream and 2 bp downstream of the open reading frame
and was constructed by replacing the 334–369 region in pRS316-STE20334–
369 (27) (Table 2) with wild-type sequences from pRL116 as a BamHI-SalI
fragment. In theory, pPP1001 should be identical to pRS316-STE20 (27).
As mentioned in the text, the results with these plasmids suggest that they may
mildly underexpress STE20, possibly due to the absence of native downstream
sequences such as transcriptional terminators. This is more evident with the
“native” (pPP1001-based) constructs than with the GFP fusion (pRL116-based)
constructs. In order to minimize confusion and to facilitate comparison to pre-
vious work, Table 3 compares the basic features of several STE20 plasmids and
their ability to complement ste20 cells for pheromone-induced transcription.
The results indicate that the GFP-STE20 fusion construct most closely approx-
imates the level of function supplied by either the genomic STE20 allele or a
construct (pSTE20–5) containing STE20 on a large genomic fragment, whereas
the native construct (pPP1001) appears to underexpress STE20, in that it pro-
vides only 30 to 40% of these levels (see Table 3; also see Fig. 2).
Plasmids pPP1010, pPP1011, and pPP1062 contain the ste20334–369 muta-
tion transferred into pRL116, pPP1001, and pB20N2, respectively, by replace-
ment of their BamHI-SalI fragments with the analogous fragment from pBTL56
(27) (Table 2). In theory, plasmid pPP1011 should be identical to pRS316-
STE20334–369 (27). Also, pPP1010 (the 334–369 derivative of pRL116) is
highly similar to pBTL56 (27). See Table 3 for comparisons.
Point mutations were first generated in pRL116 by Pfu polymerase-mediated
extension of complementary mutagenic oligonucleotides, according to the
Quick-Change site-directed mutagenesis kit (Stratagene). To ensure that the
phenotypes did not arise from spurious mutations elsewhere, restriction frag-
ments were transferred back into unmutagenized plasmids, and the transferred
fragments were sequenced to confirm the presence of only the desired muta-
tion(s). Mutations S338A, H345G, and L369G were transferred on BamHI-SalI
fragments. These fragments were transferred into the GFP-STE20 plasmid
pRL116, the non-GFP fusion construct pPP1001, and the two-hybrid constructs
pB20N2 and pPP1037 to generate the mutant derivatives listed in Table 2. The
S338A/H345G double and S338A/H345G/L369G triple mutants were generated
by sequential rounds of mutagenesis, followed by BamHI-SalI fragment transfer
as for the single mutants. All point mutations are marked by the gain or loss of
a restriction site as follows: S338A, loss of EcoRV; H345G, gain of EcoRI; and
L369G, gain of KpnI.
The GAL1pr-ste20 mutant constructs pPP1248, pPP1272, pPP1273, and
pPP1274 contain the SpeI-SgrAI fragments from pPP1010, pPP1117, pPP1009,
and pPP1109, respectively, transferred into pDH166 (27). Plasmids pPP1042 and
pPP1043 contain the NotI-XhoI fragments from pPP1005 and pPP1011, respec-
tively, transferred into pRS306.
Plasmid pB20N2 was constructed by PCR of sequences encoding Ste20 resi-
dues 1 to 499, using pSTE20–5 as the template, and insertion into pBTM116 (5)
as an EcoRI-PstI fragment; a silent mutation from the downstream PCR primer
disrupts the EcoRI site normally upstream of STE20 codon 499. pPP1309 was
constructed by PCR of sequences encoding Ste20 residues 580 to 939, using
pRD56-K649M (16) as the template to incorporate the K649M mutation, and
insertion into pBTM116 as a BamHI-PstI fragment. pPP1037 was created by
PCR of sequences encoding Ste20 residues 1 to 439, using pSTE20–5 as the
template, transferred first as an EcoRI-PstI fragment into pGAD424 and then as
an EcoRI-BglII fragment into pGADXP.
Plasmid pPP1027 was constructed by PCR amplification of CDC42G12V from
pGAL-CDC42-Val12 (69), with the C188S mutation introduced by the down-
stream primer, and insertion into pGAD424 as an EcoRI-PstI fragment. pH-
G42-L61 contains the GAL10pr-CDC42Q61L cassette from pGAL-CDC42-Leu61
(69) transferred as a BamHI-XhoI fragment into pRS413. Plasmids pPP827,
pPP1252, and pPP1253 are LEU2-marked derivatives of pFRE(Ty1)::lacZ (33),
p3941, and p3782 (53), respectively, created by homologous recombination in S.
cerevisiae using the marker swap construct pUC4-ura3::LEU2 (38) digested with
HindIII. pPP1219 contains the GAL1 promoter from pPP450 transferred into
pRS413 as a SacI-ApaI fragment. Plasmid pH-SL2 was created by transferring
the BamHI-BamHI insert from pSL2 (54) into the BamHI site of pPP1219.





W303a KBY211 MAT ste20::ADE2 cla4::LEU2  YCp TRP1-
cla4-75ts
PPY398 MATa
PPY496 MATa FUS1::FUS1-lacZ::LEU2 ste20-1::TRP1
PPY640 MATa FUS1::FUS1-lacZ::LEU2
PPY866 MAT FUS1::FUS1-lacZ::LEU2 ste20-1::TRP1
ste5::ADE2 ste4::ura3FOA
PPY913 MATa FUS1::FUS1-lacZ::LEU2 ste20-3::TRP1
PPY1203 MATa FUS1::FUS1-lacZ::LEU2 ste20-334–369








1278b PPY966 MATa his3::hisG leu2::hisG trp1::hisG ura3-52
PPY1200 MATa his3::hisG leu2::hisG trp1::hisG ura3-52
ste20-334–369
PPY1202 MATa his3::hisG leu2::hisG trp1::hisG ura3-52
ste20-S338A/H345G
PPY1209 MATa his3::hisG leu2::hisG trp1::hisG ura3-52
ste20-1::TRP1
S288C PPY760 MATa ade2 his3 leu2 trp1 LYS2::lexAop-HIS3
URA3::lexAop-lacZ far1::ADE2
Other PT2 MAT hom3 ilv1 can1
a W303 is ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 can1.
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-Galactosidase assays. For liquid assays, cells (usually 1 ml of culture) were
harvested by centrifugation and then resuspended in 0.5 ml of Z-buffer (5) and
processed as described before (46).
Pheromone response assays. Halo assays of growth arrest were performed by
spreading 3  105 cells/plate on Ura plates, then applying sterile filter disks
containing 20 	l of 1 mM -factor, and incubating for 3 days at 30°C.
For FUS1-lacZ transcriptional induction assays, cells were grown overnight at
30°C to mid-exponential phase (optical density at 660 nm [OD660] 
 0.3 to 0.6)
in selective (plasmid alleles) or complete (integrated alleles) glucose medium
and then incubated with and without 5 	M -factor for 2 h before harvesting 1
ml for the -galactosidase assay. For FUS1-lacZ activated by galactose-inducible
constructs, cells were grown overnight in selective raffinose medium to the
mid-exponential phase and then induced with 2% galactose for 3 h before
harvest.
For quantitative mating assays, cells were grown overnight to the mid-expo-
nential phase in selective or complete glucose medium, as appropriate, and then
5  106 a cells were mixed with 107 PT2 partner cells and collected onto filters,
and the filters were placed onto complete glucose plates. After 4 h of mating at
30°C, cells on the filters were suspended in liquid, and serial dilutions were plated
on medium selective for diploids. Mating efficiency was calculated as the per-
centage of input a cells that formed diploids; the number of input cells was
determined by plating a dilution of the a cell cultures on selective (plasmid) or
complete (integrated) plates at the start of the mating assay.
Patch mating assays were performed by patching a cell transformants directly
onto a lawn of PT2 partner cells, incubating overnight at 30°C, replicating to
minimal medium to select for diploids, and then incubating for 2 days at 30°C.
Yeast cell lysates and kinase assays. Transformants were grown in selective
medium overnight at 30°C to an OD660 of 0.6 to 1.0. For kinase assays involving
Cdc42Q61L, transformants were first grown in His/raffinose medium and then
induced with galactose (2% final) for 90 min. Equivalent numbers of cells
(usually 1  108 to 4  108) were harvested by centrifugation at 4°C, suspended
in residual supernatant, transferred to an ice-cold microcentrifuge tube, and
recentrifuged for 30 s in the cold; the supernatant was aspirated, and the pellets
were stored at 80°C. Pellets were thawed by addition of 1 ml of ice-cold buffer
A (25 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM dithiothreitol [DTT], 2 mM
EDTA, 10% glycerol, 50 mM NaF, 1 mM phenylmethylsulfonyl fluoride
[PMSF]), washed once with 1 ml of buffer A, and then resuspended in 350 	l of
buffer B (buffer A containing 0.1% Triton X-100 and 1 mM Na3VO4 plus
protease inhibitors [PIs: 20 	g of 4-(2-aminoethyl)-benzenesulfonyl fluoride, 2
	g of leupeptin, 1 	g of pepstatin, and 1 	g of aprotinin per ml]), kept cold
throughout. Approximately 0.4 ml of glass beads was added, followed by three
1-min pulses at full speed in a multitube vortexer (VWR Scientific Products
Corp.), with 30 s on ice between pulses. Additional Triton X-100 was added (40
	l of a 10% solution), and the lysate was mixed on a nutator for 10 min.
Following 2 min of centrifugation, the supernatant was transferred to a fresh
tube and centrifuged for 4 min, and the new supernatant containing the clarified
lysate was transferred to a fresh tube.
Epitope-tagged Ste20 was immunoprecipitated by adding 2 	g of anti-GFP
monoclonal (clones 7.1 and 13.1; Boehringer Mannheim) or 0.4 	g of anti-Myc
monoclonal (9E10; Santa Cruz Biotech.) to the clarified lysate and mixing for 2 h
at 4°C. Protein G beads (Sigma; 40 	l of a 50% slurry in buffer A) were added
and mixed for 1 h. Beads were pelleted at 2,400  g, washed three times with 200
	l of cold buffer B and once with 200 	l of kinase buffer (KB; 10 mM Tris-HCl
[pH 7.4], 10 mM MgCl2). Residual supernatant was removed using a 26-gauge
needle, and beads were resuspended in 20 	l of room-temperature KB plus PIs.
Then 10 	l of kinase assay cocktail (KB containing 1 mg of myelin basic protein
per ml, 50 	M ATP, and 0.8 	M [-32P]ATP [3,000 Ci/mmol]) was added, and
incubation proceeded for 30 min in a 30°C bath with occasional gentle mixing.
Reactions were stopped by adding 20 	l of 2.5 sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) sample buffer, boiling for 2 min,
and then centrifuging for 5 min.
To analyze phosphorylation, 15 	l was run on an SDS–15% PAGE gel, and the
gel was dried and exposed to a Phosphorimager screen (Molecular Dynamics).
To determine Ste20 levels, 15 	l was run on an SDS–7% PAGE gel, followed by
semidry transfer to an Immobilon-P membrane (Amersham); epitope-tagged
Ste20 was detected by using rabbit anti-GFP polyclonal antibody (K. Gould
laboratory, Vanderbilt University; a gift of D. McCollum) or mouse anti-Myc
monoclonal antibody (9E10; Santa Cruz Biotechnology) at a 1:1,000 dilution,
followed by alkaline phosphatase-conjugated secondary antibody diluted 1:3,000
(goat anti-rabbit or anti-mouse immunoglobulin; Bio-Rad) and chemilumines-
cence with Immun-Star substrate (Bio-Rad).
Filamentation assays. Agar invasion assays were performed as previously
described (51). Cells were patched onto YPD plates and incubated for 3 days at
TABLE 2. Plasmids used in this study
Plasmid Description Referenceor source
pBTL56 CEN URA3 GFP-ste20334–369 27
pRL116 CEN URA3 GFP-STE20 27
pPP964 pRL116 ste20-S338A This study
pPP965 pRL116 ste20-H345G This study
pPP1009 pRL116 ste20-S338A/H345G This study
pPP1010 pRL116 ste20-334–369 This study
pPP1109 pRL116 ste20-S338A/H345G/L369G This study
pPP1117 pRL116 ste20-L369G This study
pRS316-STE20
(334–369)
CEN URA3 ste20334–369 27
pPP1001 CEN URA3 STE20 This study
pPP1002 pPP1001 ste20-S338A This study
pPP1003 pPP1001 ste20-H345G This study
pPP1005 pPP1001 ste20-S338A/H345G This study
pPP1011 pPP1001 ste20-334–369 This study
pPP1112 pPP1001 ste20-S338A/H345G/L369G This study
pPP1118 pPP1001 ste20-L369G This study
pRS306 URA3 integrating 57
pPP1042 pRS306 ste20-S338A/H345G This study
pPP1043 pRS306 ste20-334–369 This study
pDH166 CEN HIS3 GAL1pr-STE20 27
pPP1248 pDH166 ste20-334–369 This study
pPP1272 pDH166 ste20-L369G This study
pPP1273 pDH166 ste20-S338A/H345G This study
pPP1274 pDH166 ste20-S338A/H345G/L369G This study
pBTM116 2	m TRP1 lexA DBD vector 5
pB20N2 2	m TRP1 lexA DBD-ste20 1–499 This study
pPP1059 pB20N2 ste20-S338A This study
pPP1060 pB20N2 ste20-H345G This study
pPP1061 pB20N2 ste20-S338A/H345G This study
pPP1062 pB20N2 ste20-334–369 This study
pPP1115 pB20N2 ste20-S338A/H345G/L369G This study
pPP1119 pB20N2 ste20-L369G This study
pPP1309 2	m TRP1 lexA DBD-ste20 580–939
(K649M)
This study
pGAD424 2	m LEU2 GAL4 AD vector 5
pPP1027 2	m LEU2 GAL4 AD-CDC42-
G12V/C188S
This study
pRL51.1 2	m LEU2 GAL4 AD-BEM1 157–551 28
pGADXP 2	m LEU2 ADH1pr (full-length) GAL4
AD vector
11
pPP1037 2	m LEU2 ADH1pr (full-length) GAL4
AD-ste20 1–439
This study
pPP1321 pPP1037 ste20-L369G This study
pPP1322 pPP1037 ste20-334–369 This study
pPP1323 pPP1037 ste20-S338A/H345G This study
pRS316 CEN URA3 57
pRS314 CEN TRP1 57
pRS413 CEN HIS3 57
pPP1219 CEN HIS3 GAL1pr This study
pPP827 2	m LEU2 TyFRE-lacZ This study
pPP1252 2	m LEU2 flo11(10/9)-lacZ This study
pPP1253 2	m LEU2 FLO11pr-lacZ This study
p2988 CEN LEU2 YLR042Cpr-lacZ 50
p2987 CEN LEU2 KSS1pr-lacZ 50
pGSM ste20::12myc STE20 C-term::myc12 URA3 D. Lew
pSTE20-5 CEN URA3 STE20 26
pH-G42-L61 CEN HIS3 GAL10pr-CDC42O61L This study
pH-GS5-CTM CEN HIS3 GAL1pr-STE5-CTM 47
pH-SL2 CEN HIS3 GAL1pr-His6-myc-STE5
(P44L)-GST
This study
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30°C and then for 2 days at room temperature. Plates were photographed before
and after being rinsed under a gentle stream of deionized water. Filamentation
reporter expression was measured in exponentially growing cultures, prepared by
diluting overnight cultures into fresh glucose medium (lacking appropriate nu-
trients to maintain plasmid selection) to an OD660 of 0.2 to 0.3 and incubating at
30°C for at least 3 h before harvest.
Microscopy. Transformants were grown at 30°C in Ura/glucose medium
containing extra adenine (0.008%) to inhibit accumulation of fluorescent pig-
ment in ade2 cells. Cells were examined without fixation under a Nikon E600
epifluorescence microscope equipped with a 50 Plan oil-immersion objective,
and images were captured using a cooled black and white charge-coupled device
camera (DAGE-MTI, Inc.).
RESULTS
Pheromone-responsive signaling requires Cdc42-Ste20 in-
teraction. Previous studies tested the role of the Cdc42-Ste20
interaction in pheromone response by deleting the entire Ste20
CRIB domain (27, 45). To reexamine this issue, we made point
mutations at two highly conserved residues in the Ste20 CRIB
domain (Fig. 1A and B), changing Ser338 to Ala (S338A) or
His345 to Gly (H345G). Alteration of the homologous resi-
dues in human and S. pombe PAKs disrupts Cdc42 binding (59,
66, 68). The Ste20 mutations were also combined to make an
S338A/H345G double mutant.
To test for effects on binding, the mutations were introduced
into a two-hybrid fusion construct containing Ste20 residues 1
to 499. To assay function, they were introduced into low-copy-
number vectors encoding either native Ste20 or a GFP-Ste20
fusion protein, each expressed from the STE20 promoter. We
found it useful to study the mutations in both expression con-
texts, as they appeared to confer different levels of function—
e.g., the native constructs gave lower signaling and thus re-
vealed the subtle defects of mild mutations, whereas the GFP
constructs gave higher signaling and thus revealed the residual
function of severe mutations (see Table 3, Materials and Meth-
ods, and also Fig. 2 below). For comparison to the point mu-
tations, a CRIB domain deletion (334–369) studied previ-
ously (27, 45) was introduced into all of the same vectors.
Cdc42 binding, measured by a two-hybrid assay (Fig. 1C),
was disrupted by the point mutations to various degrees:
S338A showed the mildest defect, H345G showed a stronger
defect, and the S338A/H345G double mutant showed the
strongest defect, which approximated that observed with the
complete CRIB domain deletion (334–369). These effects
were specific to Cdc42, as the mutations did not interfere with
binding to Bem1 in a similar assay (Fig. 1C). The subcellular
localization of GFP-Ste20 harboring these mutations was con-
sistent with loss of Cdc42 binding (27, 39, 45), as all mutants
showed loss of the sharp peripheral fluorescence at bud tips
(Fig. 1D), including that with the weakest Cdc42-binding de-
fect, S338A.
Importantly, we found that the point mutants showed de-
fects in mating pathway function that paralleled their Cdc42-
binding defects (Fig. 2A), with the S338A mutant showing mild
defects, H345G showing stronger defects, and the S338A/
H345G mutant showing very strong defects that approached
the null phenotype. This pattern was observed in all assays of
mating pathway function, including growth arrest, transcrip-
tional induction (FUS1-lacZ), and mating ability. In stark con-
trast to these point mutants, the mutant lacking the entire
CRIB domain (334–369) was largely signaling competent
(e.g., roughly 50-fold-higher FUS1-lacZ induction and 1,000-
fold-higher mating efficiency than the S338A/H345G mutant)
despite negligible Cdc42 binding. These results suggest that
interaction with Cdc42 is normally critical for Ste20 to function
in the mating pathway, whereas deletion of the CRIB domain
bypasses this requirement.
In order to rule out the possibility that these pheromone
response defects result from disruption of binding between
Ste20 and G (29), we assayed signaling that was initiated by
a membrane-targeted derivative (Ste5-CTM) of the kinase cas-
cade scaffold protein Ste5, which bypasses the requirement for
G but still depends on Ste20 (47). In this setting (Fig. 2B),
the CRIB domain mutants showed a spectrum of defects sim-
ilar to those found when signaling was initiated by pheromone;
in the most extreme case, FUS1-lacZ induction in the S338A/
H345G double mutant was reduced to roughly 1% of the
wild-type level. These data are consistent with the pheromone
response assays and show that the signaling defects are not
caused by defective Ste20-G interaction. In addition, be-
cause of the absence of Ste4 (G) and pheromone in these
experiments, they demonstrate that the signaling role of the
Cdc42-Ste20 interaction operates independently of receptor
activation and does not require regulatory input from phero-
mone or G.
We also integrated into the genomic STE20 locus the two
TABLE 3. Comparison of different STE20 and ste20334–369 plasmids
Strain Plasmida
Native STE20 sequence (bp)
STE20 allele Mean FUS1-lacZ expression
b
(U)  SDUpstream Downstream
PPY640 (STE20) pRS316 1,000 1,000 STE20 (genomic) 80  16
PPY913 (ste20) pSTE20-5 1,000 1,000 STE20 68  18
pRL116 480 30 GFP-STE20 72  15
pPP1010 480 30 GFP-ste20334–369 27  13
pBTL56 480 0 GFP-ste20334–369c 27  8.2
pPP1001* 1,210 2 STE20 25  9.4
pPP1011* 1,210 2 ste20334–369 5.2  3.5
pRS316-STE20334–369* 1,210 2 ste20334–369 4.2  1.7
pRS316 Vector 0.05  0.04
a In some plasmids (), STE20 was inserted into the pRS316 vector in an opposite orientation from the others. Conceivably, transcriptional termination is governed
by vector sequences in all plasmids except pSTE20-5, and thus different downstream vector sequences in the two orientations may contribute to the different levels of
function. A polyadenylation sequence was predicted to lie 149 bp downstream of the open reading frame (26).
b Mean -galactosidase units  SD (n 
 12), measured after 2 h of exposure to 5 	M -factor.
c The STE20 open reading frame in pBTL56 is extended by two codons at the C terminus.
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alleles with the strongest Cdc42-binding defects, S338A/
H345G and 334–369. In both mating and transcriptional in-
duction assays, these alleles showed opposing phenotypes: the
S338A/H345G mutant was nearly null, while the 334–369
mutant was nearly wild type (Fig. 2C). These results largely
confirm the results with plasmid-borne alleles, though one
difference was notable: the ability of the 334–369 allele to
approach wild-type levels of function was greatest when inte-
grated (e.g., 76% of wild-type FUS1-lacZ), and when it was
plasmid-borne, function was greater for the GFP fusion (40%
of wild-type level) than for the native, non-GFP derivative
(14% of wild-type level). Thus, whether the CRIB deletion
form behaves as largely competent or as significantly defective
can depend on the expression context (see also Table 3). This
pattern is important when comparing the effects of CRIB do-
main deletion on different pathways (such as mating versus
filamentation pathways; see below). For example, the conclu-
sion that Ste20334–369 is defective at diploid pseudohyphal
growth (27) derived from a comparison of plasmids (pSTE20–5
versus pRS316-STE20334–369) in which wild-type and mu-
FIG. 1. Mutations to test whether the Ste20 CRIB domain behaves as a Cdc42-regulated autoinhibitory domain. (A) Model for activation of
Ste20, supported by this study, involving transition between low-activity (closed) and high-activity (open) conformations. The CRIB domain (grey)
is indicated as having regions that bind Cdc42 (notch) or the kinase domain (bump). Asterisks denote residues mutated in this study. The
G-binding domain was defined previously (29). (B) Alignment of CRIB domains in PAKs from S. cerevisiae (S.c.), S. pombe (S.p.) and Homo
sapiens (H.s.). Residues identical in three or more proteins are boxed in black, and mutated residues are indicated (). Also indicated are human
PAK1 residues (30, 37, 66, 68) involved in binding Cdc42 (caret) or the PAK1 kinase domain (). A consensus CRIB motif is shown at the bottom;
sequences C-terminal to this motif are well conserved among PAKs (68) but not between PAKs and other Cdc42 targets, such as mammalian
WASP and ACK or yeast Gic1 and Gic2 (8, 37). (C) Effects of CRIB domain mutations on binding to Cdc42 and Bem1, measured by two-hybrid
assay. Wild-type (pB20N2) and mutant (pPP1059, pPP1060, pPP1061, and pPP1062) derivatives of a DNA-binding-domain fusion to Ste201–499
were coexpressed in PPY760 with activation domain fusions to Bem1157–551 (pRL51.1) or Cdc42G12V/C188S (pPP1027), or with vector (pGAD424).
-Galactosidase measurements (mean  standard deviation [SD]; n 
 4) were normalized to the wild-type (WT) Ste20 allele (
 100%) for each
binding partner; values in parentheses are the mean units for the wild-type interactions. The negative control (control) gives the basal signal of
pB20N2 with pGAD424 (mean units 
 0.04); the mutant derivatives of pB20N2 gave similar basal signals (not shown). (D) Effects on subcellular
localization. Representative fluorescence images of cells (PPY913) expressing the indicated GFP-Ste20 mutants or carrying only a vector (pRS316).
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tant alleles were expressed in different contexts, and which we
found also differed by roughly 15-fold for FUS1-lacZ induction
(see Table 3). Overall, our observations indicate that deletion
of the CRIB domain creates a hypomorphic form of Ste20 that
is mildly compromised for mating pathway signaling, to a de-
gree that may be enhanced in contexts of reduced expression.
Cdc42 binding is required to antagonize autoinhibitory in-
teraction between Ste20 CRIB and kinase domains. To address
the possibility that something special about the extensive size
of the 334–369 deletion allows it to bypass the requirement
for Cdc42 binding or that something detrimental about the
point mutations makes them defective for reasons unrelated to
Cdc42 binding, we tested whether the S338A/H345G double
mutant could be rescued by a third point mutation at Ste20
residue Leu369 (L369G), at the downstream end of the CRIB
domain (see Fig. 1A and B). In other PAKs, mutation at the
analogous residue interferes with intramolecular interaction
between the CRIB and kinase domains (9, 59, 66). Thus, we
predicted that if Ste20 can adopt an autoinhibited conforma-
tion, the L369G mutation might disrupt this conformation and
render Ste20 Cdc42 independent.
Indeed, the L369G mutation on its own had little effect on
either Cdc42 binding or signaling by Ste20, but it showed a
dramatic ability to suppress the signaling defects of the S338A/
H345G mutation, and did so without restoring Cdc42 binding
(Fig. 3A). This indicates that the Cdc42-Ste20 interaction is
primarily required to relieve the negative influence of Leu369
and that loss of Leu369 is sufficient to explain the Cdc42-
independent behavior of the larger 334–369 deletion.
Consistent with these observations, we were able to detect a
specific interaction between the Ste20 C-terminal kinase do-
main and an N-terminal fragment containing the CRIB do-
main in a two-hybrid assay (Fig. 3B and C). Importantly, this
interaction was eliminated by each of the CRIB domain mu-
tations that conferred Cdc42-independent signaling—i.e., the
large deletion (334–369) and the L369G point mutation. In
contrast, the interaction was not disrupted by the double mu-
tation (S338A/H345G), which produced the most severe pher-
omone response defect (and which actually increased the
CRIB-kinase interaction signal, perhaps by reduced interfer-
ence from endogenous Cdc42). Therefore, the Ste20 CRIB
domain interacts both with Cdc42 (via S338 and H345) and
FIG. 2. Interaction between the Ste20 CRIB domain and Cdc42 is required for mating pathway function, in a manner that is bypassed by CRIB
domain deletion. (A) CRIB domain point mutations reduce pheromone response in proportion to their Cdc42-binding defect. Strain PPY913
harbored a vector (pRS316) or the indicated STE20 plasmids in either native (pPP1001-based) or GFP fusion (pRL116-based) contexts. Tests of
pheromone-induced growth arrest (left) and FUS1-lacZ expression (middle) and of mating efficiency (right) were done as described in Materials
and Methods. (B) Signaling role of the Cdc42-Ste20 interaction is independent of pheromone and G. FUS1-lacZ induction was stimulated
without addition of pheromone and in the absence of G (Ste4) by galactose-induced synthesis of Ste5-CTM (pH-GS5-CTM) in an ste4 ste5
ste20 strain (PPY866). The strain also harbored a vector (pRS316) or the indicated GFP-STE20 mutant plasmid. (C) Mating and FUS1-lacZ
results using alleles integrated at the genomic STE20 locus. Strains were PPY496, PPY640, PPY1205, and PPY1203. F, -factor. In A to C, bars
indicate mean  SD for three or more repeats.
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with the kinase domain (via L369), and the role of the former
(Cdc42-CRIB) interaction is to antagonize the negative effect
of the latter (CRIB-kinase) interaction.
Cdc42 binding stimulates Ste20 kinase activity by relief
of autoinhibition. We tested the kinase activity of all of the
Ste20 mutants upon immunoprecipitating the GFP fusion
derivatives from cell lysates using anti-GFP antibodies (Fig.
4A). We found that kinase activity was elevated three- to
fourfold for the three mutants whose signaling properties sug-
gested they are Cdc42 independent, namely, Ste20334–369,
Ste20S338A/H345G/L369G, and Ste20L369G. This hyperactivity
supports the contention that these mutations disrupt an auto-
inhibited conformation of Ste20, although it was not observed
in previous studies of Ste20 deleted for the CRIB domain (see
Discussion).
Surprisingly, we did not observe reduced kinase activity with
the signaling-deficient mutants (Fig. 4A), even for the mutant
showing the strongest signaling defect in vivo, S338A/H345G.
We considered the possibility that only a small fraction of
wild-type molecules are fully active at any one time in the cell,
and thus any reduction in this fraction may be masked by an
excess of low-activity molecules or perhaps by molecules that
become activated by unfolding during cell lysis. Therefore,
we tested whether the level of active Ste20 in vivo could be
boosted by increasing the amount of GTP-bound Cdc42,
using the GTPase-deficient mutant Cdc42Q61L (Fig. 4B).
Indeed, galactose-induced expression of Cdc42Q61L stimu-
lated the kinase activity of wild-type Ste20 (Ste20WT). In
contrast, Ste20S338A/H345G could not be stimulated, whereas
Ste20334–369 activity was constitutively elevated and was not
further increased by Cdc42Q61L. These results show clearly
that the kinase activity of Ste20 can be stimulated by Cdc42
in vivo. Furthermore, they suggest that the signaling defects of
Ste20S338A/H345G result from an inability to become stimulated
by Cdc42, whereas the Cdc42-independent kinase activity of
Ste20334–369 (or Ste20S338A/H345G/L369G) allows signaling with-
out binding Cdc42.
We also took advantage of our ability to detect Cdc42-
mediated stimulation of Ste20 to revisit the issue of whether
pheromone stimulates Ste20 kinase activity, but we found no
effect (Fig. 4B, far right lane). This is consistent with a previous
report (65), and hence there remains no evidence that phero-
mone can stimulate Ste20 kinase activity. Moreover, because it
did not mimic expression of Cdc42Q61L, pheromone treatment
also does not produce an obvious increase in the levels of
GTP-bound Cdc42. While it remains possible that such effects
do occur (see Discussion), the alternative scenario raised by
these observations is that Cdc42 and Ste20 activities per se may
be uninfluenced by pheromone.
L369G highlights separable roles for Cdc42 in Ste20 kinase
activity and function. It has been observed previously that
overexpression of a fragment encoding only the kinase do-
main of Ste20 (Ste20N) is toxic due to disruption of actin
organization (27, 49). Consistent with their hyperactive ki-
FIG. 3. The Ste20 CRIB domain behaves as an autoinhibitory do-
main. (A) Mutation of Leu369 is sufficient to allow Ste20 to signal without
binding Cdc42. FUS1-lacZ and mating assays used strain PPY913 har-
boring the vector (pRS316) or plasmids encoding the indicated native
Ste20 or GFP-Ste20 derivatives, similar to Fig. 2. Bars, mean  SD (n

 4). Cdc42 binding two-hybrid results show mean -galactosidase
units (n 
 3) from PPY760 cells cotransformed with pPP1027 and
either pBTM116, pB20N2, pPP1119, pPP1061, or pPP1115. (B) Sche-
matic diagram of interaction between CRIB and kinase domains, as
detected by two-hybrid analysis (in panel C) using activation domain
(AD) and DNA-binding domain (DBD) fusions to the indicated Ste20
fragments. Positions of point mutations are denoted by asterisks as in
Fig. 1A. (C) CRIB-kinase interaction results. Strain PPY760 harbored
plasmids encoding the indicated DNA-binding domain fusions
(pPP1309, pB20N2, and pBTM116) in combination with the vector
(pGADXP) or activation domain fusions to wild-type (WT) and mu-
tant derivatives of Ste20 residues 1 to 439 (pPP1037, pPP1321,
pPP1322, and pPP1323). The kinase domain fragment (580 to 939)
bears a kinase-inactivating mutation, K649M, in order to prevent tox-
icity. Values are means  SD (n 
 5).
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nase activity, we found that Ste20334–369, Ste20L369G, and
Ste20S338A/H345G/L369G were also toxic when overexpressed
from the GAL1 promoter, whereas wild-type Ste20 and the
signaling-deficient mutant Ste20S338A/H345G were not (Fig. 5A).
Despite their similar kinase activities and toxicities, how-
ever, the L369G mutant differs from the other two hyperactive
mutants in that it retains the ability to bind Cdc42. This
prompted us to ask whether Cdc42 binding might still contrib-
ute to Ste20 function—e.g., by localization—even when kinase
activity is deregulated. Two phenotypes indicate that it does.
FIG. 4. Ste20 kinase activity and stimulation by Cdc42-GTP.
(A) Hyperactive kinase activity displayed by Cdc42-independent Ste20
mutants. Strain PPY913 was transformed with the indicated GFP-
STE20 plasmids or pRS316 (vector). Ste20 mutant proteins were im-
munoprecipitated with anti-GFP antibodies and tested for kinase ac-
tivity by using myelin basic protein (MBP) as the substrate. Portions of
the kinase reactions were also analyzed by anti-GFP immunoblot to
determine protein levels. Bottom, quantification of two independent
experiments (mean  range), normalized in each experiment to the
level of [32P]MBP in the wild-type (WT) sample (
 1). (B) Cdc42-GTP
stimulates kinase activity of wild-type but not mutant Ste20 derivatives.
Ste20 kinase activity was assayed using strains PPY1234, PPY1238, and
PPY1236, expressing Myc12-tagged wild-type, S338A/H345G, and
334–369 derivatives of Ste20, respectively. The strains harbored a
vector (pRS413) or a galactose-inducible CDC42Q61L construct (pH-
G42-L61), as denoted by  and  GAL-CDC42Q61L, respectively.
Transformants were induced with 2% galactose for 90 min in the
absence () or presence () of 10 	M -factor as indicated. The
Myc12-tagged proteins were immunoprecipitated, assayed for kinase
activity, and tested for Ste20-Myc protein levels, as for panel A. Bot-
tom, quantification of two independent experiments as in panel A.
FIG. 5. Additional contribution of Cdc42 to Ste20 function, sepa-
rable from kinase activity. (A) Hyperactive kinase mutants are toxic
when overexpressed. Strain PPY398 was transformed with pPP1219,
pDH166, pPP1248, pPP1272, pPP1274, or pPP1273, and then fivefold
serial dilutions were spotted onto His/glucose or His/raffinose/
galactose plates, as indicated, and incubated for 3 days at 30°C.
(B) Loss of Cdc42-binding, not deregulated Ste20 activity, disrupts the
Cla4-redundant essential function of Ste20. Strain KBY211 (ste20
cla4 YCp-TRP1-cla4–75ts) was transformed with the indicated GFP-
STE20 plasmids, and then fivefold serial dilutions were spotted onto
Ura plates and incubated for 3 days at 25 or 37°C, as indicated.
(C) Loss of Cdc42 binding decreases Ste20 signaling activity even when
kinase activity is already made Cdc42 independent by the L369G
mutation. Strain PPY866 harbored the indicated GFP-STE20 plasmids
plus either pH-GS5-CTM (Ste5-CTM) or pH-SL2 (Ste5P44L-GST).
Bars show FUS1-lacZ induction (mean  SD, n 
 3) after galactose-
induced synthesis of the indicated Ste5 derivative.
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First, we compared the CRIB domain mutants for their ability
to perform an essential cell polarization function (13, 22) that
is redundant with a related kinase, Cla4 (Fig. 5B). Previous
work showed that this function was impaired by removal of the
Ste20 CRIB domain (27, 45), which, in light of our results,
could indicate that cells lacking Cla4 are sensitized to either
delocalization or hyperactivity of Ste20. We found that the
Ste20L369G mutant was distinguishable from the other two hy-
peractive mutants in that it remained capable of supporting
growth when Cla4 was inactivated. This suggests that it is
delocalization, not deregulated kinase activity alone, that
causes loss of the essential (Cla4-redundant) function in the
Ste20334–369 and Ste20S338A/H345G/L369G mutants.
Second, we tested mating pathway signaling initiated by tar-
geting Ste5 to the plasma membrane (47), using Ste5-CTM
(Fig. 5C, top). Of the three hyperactive kinase mutants, sig-
naling was demonstrably stronger for Ste20L369G than for the
other two (Ste20334–369 and Ste20S338A/H345G/L369G), suggest-
ing that retention of Cdc42 binding allows Ste20L369G to signal
more efficiently. Curiously, similar results were observed with a
Ste5 reagent (54) that is not explicitly targeted to the periph-
ery, but instead is activated by a combination of mutation and
fusion to GST (Ste5P44L-GST; Fig. 5C, bottom). This suggests
either that the function of Cdc42 binding which is disrupted in
the Ste20334–369 and Ste20S338A/H345G/L369G mutants can af-
fect Ste5 signaling that is unlocalized or that signaling by
Ste5P44L-GST is still initiated primarily at the cell periphery
(see Discussion); relevant to this latter possibility, signaling by
this form of Ste5 is considerably stronger when G is present
(R. E. Lamson and P. M. Pryciak, unpublished observations).
Filamentation pathway signaling. Ste20 also functions in a
signal transduction pathway that governs filamentous growth
(31, 51). To analyze the role of Cdc42-Ste20 binding in this
pathway, we replaced the genomic STE20 gene with the
S338A/H345G and 334–369 alleles in cells of the 1278b
strain background, which is necessary for tests of filamentous
growth (19, 51). The relative ability of these two alleles to
function in the filamentation pathway paralleled that for the
mating pathway—i.e., the S338A/H345G double mutant re-
sembled a ste20 null mutant, whereas the 334–369 mutant
was nearly wild type for agar invasion ability (Fig. 6A). This
was confirmed quantitatively (Fig. 6B) by assaying transcrip-
tional expression from several different Tec1- and Kss1-depen-
dent reporter constructs (33, 34, 50). All reporters were
strongly reduced by the S338A/H345G double mutant. The
334–369 mutant, on the other hand, was indistinguishable
from the wild type for two reporters (TyFRE and FLO11) and
mildly reduced for two other reporters (YLR042C and KSS1),
reminiscent of its mild deficiency in the mating pathway.
Our results with the CRIB deletion mutant were surprising
in light of prior reports that concluded it was defective for
filamentation pathway function (27, 45). Previous tests used
plasmid-borne STE20 alleles, which may enhance mild signal-
ing defects (see above). We were unable to observe robust agar
invasion using plasmid-borne alleles (data not shown), but we
did compare them for transcriptional reporter expression (Fig.
6C). These tests yielded a pattern similar to that found for the
integrated alleles, with the S338A/H345G double mutant ap-
proximating the null phenotype and the 334–369 mutant
showing an intermediate phenotype in which the severity was
dependent on the reporter—i.e., either no defect (TyFRE), a
mild defect (flo11[10/9]), or a stronger defect (YLR042C).
As seen with mating pathway signaling, defects in expression
of filamentation reporters (e.g., YLR042C) were more pro-
nounced for the 334–369 mutant when plasmid borne (39%
of wild-type level) than when integrated (72% of wild-type
level). More importantly, the strong defects in filamentation
pathway signaling observed for the S338A/H345G double mu-
FIG. 6. Effects of Ste20 CRIB mutants on the filamentation path-
way. (A) Agar invasion in haploid strains PPY966, PPY1209, PPY1200,
and PPY1202. Duplicate patches of each strain were grown on a rich
medium (YPD) plate, which is shown before and after being rinsed
under a stream of water. Note that the 334–369 allele retains agar
invasion activity, which differs from previous reports of agar invasion
or pseudohyphal growth assays when this allele was tested in plasmid-
borne form (27, 45). In contrast, the S338A/H345G allele is strongly
defective. These results are representative of multiple assays and were
confirmed by using independently derived genomic replacements with
the 334–369 and S338A/H345G alleles. (B) Transcriptional expres-
sion of filamentation reporters. The strains tested in panel A harbored
the indicated lacZ reporter constructs (plasmids pPP827, pPP1253,
p2988, and p2987). Bars show -galactosidase units (mean  SD; n 

6 to 8). Note that the 334–369 allele activates the TyFRE and FLO11
reporters to a degree indistinguishable from the wild-type (WT) level
but is detectably reduced for the other two reporters. (C) Effects of
plasmid-borne alleles on filamentation reporter expression. -Galac-
tosidase activity was measured in strain PPY1209 harboring the indi-
cated lacZ reporter (pPP827, pPP1252, or p2988) plus plasmids ex-
pressing native Ste20 derivatives as follows, from top to bottom:
pPP1001, pPP1011, pPP1005, pPP1112, and pRS316. Bars show -ga-
lactosidase units (mean  SD, n 
 9). The flo11(10/9)-lacZ reporter
contains a 440-bp segment of the 3-kb promoter present in the full-
length FLO11pr-lacZ construct (53); it is included here to illustrate the
range of transcriptional effects caused by removal of the Ste20 CRIB
domain, from no effect (TyFRE and FLO11), to mild effect (flo11[10/
9]), to moderate effect (YLR042C and KSS1).
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tant were suppressed by the L369G mutation, with the result-
ing triple mutant matching the 334–369 derivative for all
reporters (Fig. 6C). This shows that for filamentation, as for
mating, Cdc42-Ste20 binding is primarily required to antago-
nize inhibitory CRIB sequences. In total, our results indicate
that rather than being qualitatively distinct (27, 45), the role of
the Cdc42-Ste20 interaction is highly similar between the mat-
ing and filamentation pathways.
DISCUSSION
In this study we have readdressed the signal transduction
role of the Cdc42-binding (CRIB) domain in Ste20, a yeast
PAK family kinase. We provide genetic and biochemical evi-
dence that Cdc42-Ste20 binding regulates Ste20 kinase activity
and signaling competence. Point mutations in the CRIB do-
main decrease pheromone response to a degree proportional
to their Cdc42-binding defect (Fig. 2), suggesting that the
Cdc42-Ste20 interaction is normally critical for pheromone
signaling. This conclusion contrasts with that made previously
from studies in which larger deletions were used to remove the
Cdc42-binding site (27, 45). In retrospect, those studies appear
to have bypassed the Cdc42 requirement (39) rather than show
it is unnecessary, because the deletions also removed inhibitory
residues immediately downstream of the CRIB consensus mo-
tif.
Indeed, we found here that the Ste20 CRIB domain inter-
acts with the kinase domain and disruption of this interaction
by mutation relieves the requirement for Cdc42 binding (Fig.
3). Our results overwhelmingly support a model in which
Cdc42 activates Ste20 by antagonizing the negative influence of
sequences within the CRIB domain (see Fig. 1A and 7). They
also complement the recent data for Cdc42 mutants that show
defects in both Ste20 binding and pheromone response (39)
and are consistent with other recent studies on PAKs from
other organisms (9, 30, 59, 66). We suggest that the basic
mechanism proposed for GTPase-mediated regulation of
PAKs (reviewed in reference 21) is shared by Ste20, indicating
that Ste20 continues to serve as a model for PAK function. Our
results with Ste20 are equally compatible with models in which
autoinhibition occurs intramolecularly (in cis) or intermolecu-
larly between members of a homodimer (in trans), as shown
recently for mammalian PAK1 (44).
Interestingly, PAKs are not alone among targets of Rho
family GTPases in being regulated by conversion between au-
toinhibited and uninhibited forms, generically termed intra-
steric regulation (25). Instead, this mechanism appears to be
common among many kinase and nonkinase targets of Rho,
Rac, and Cdc42 (7, 21, 24, 30). It is also notable that the yeast
pheromone response pathway (for a review, see reference 15)
repeatedly uses a strategy in which positive activation is ac-
complished by antagonism of a negative regulator: (i) ligand-
bound receptor activates G by inhibiting the negative effect
of the G subunit; (ii) Cdc42 activates Ste20 by inhibiting the
negative effect of the Ste20 CRIB domain; (iii) Ste20 activates
Ste11 by inhibiting the negative effect of the Ste11 N terminus;
(iv) Fus3 and Kss1 activate Ste12-mediated transcription by
inhibiting repressors of Ste12, Dig1/Rst1, and Dig2/Rst2; and
(v) release of an interaction between the N and C termini of
Ste5 may also contribute to activation of the MAP kinase
cascade (54).
We observed hyperactive kinase activity in all Ste20 mutants
with Cdc42-independent signaling ability (Fig. 4). The level of
hyperactivity (three- to eightfold) is similar to that observed
with another yeast PAK, Cla4 (6), whereas each of these is
relatively modest compared to mammalian PAKs bearing anal-
ogous mutations (9, 66). While our results are consistent with
those for other PAKs, they were not observed in previous
studies of Ste20 mutants lacking the CRIB domain (27, 45). It
is not clear why our results were different, though they were
consistent regardless of whether an N-terminal GFP tag or a
C-terminal Myc tag was used to purify Ste20. It is possible that
in prior studies, the wild-type protein was artificially activated
by unfolding to the “open” conformation, either during prep-
aration of cell lysates or by binding of polyclonal anti-Ste20
antibodies (27); alternatively, overexpression may have made
Ste20 resistant to negative regulation (45). It is also conceiv-
able that in our experiments the wild-type protein became
inactivated during lysate preparation by a mechanism to which
the 334–369 mutant is insensitive (e.g., refolding); if so, this
may have simultaneously obscured differences between the
wild type and the signaling-deficient mutants (e.g., S338A/
H345G).
Regardless of the explanation, our results indicate that there
FIG. 7. General model for the production and utilization of acti-
vated Ste20. Based on results in this study, the model proposes that
GTP-bound Cdc42 (presumably activated by its exchange factor,
Cdc24) converts Ste20 to an active form (asterisk) by antagonizing the
autoinhibitory influence of CRIB domain sequences in the Ste20 N
terminus. As discussed in the text, this conversion is required for
pheromone-dependent signaling, but there is no evidence that mating
pheromones stimulate this conversion, and instead Cdc42-activated
Ste20 is competent to signal even without prior exposure to phero-
mone. Therefore, pheromone-mediated activation of the G complex
may promote signaling through the mating pathway by an existing pool
of activated Ste20 kinase. The lifetime of activated Ste20 is unknown,
as is the degree to which Ste20 activity requires continual interaction
with Cdc42; evidence from other systems suggests that PAK autophos-
phorylation stabilizes the open conformation, allowing kinase activity
to persist after dissociation of the GTPase (10, 66). The pathway
leading to filamentous growth also requires activation of Ste20 by
Cdc42. The question mark implies that while nutritional cues can
trigger filamentous growth, they do not necessarily stimulate the Ste20-
dependent filamentation MAP kinase cascade, as discussed previously
(35); instead, nutritional cues may primarily modulate a separate (pro-
tein kinase A) pathway that is required in parallel for filamentous
growth (12, 32). Dashed-line arrows denote that Ste20 also functions in
other cellular processes (e.g., regulation of actin, cell polarity, and
osmoregulatory signaling); these likely also depend on activation by
Cdc42, but little is known about Ste20 regulation during these events.
2948 LAMSON ET AL. MOL. CELL. BIOL.
 at UNIV O
F M
ASS M








are measurable differences in kinase properties between wild-
type Ste20, signaling-deficient mutants, and Cdc42-indepen-
dent mutants which are likely to be of fundamental importance
to signaling. The toxicity resulting from overexpression of the
hyperactive mutants (Fig. 5A) independently suggests that the
kinase hyperactivity observed in vitro reflects real changes in
kinase properties in vivo.
We also found that Ste20 kinase activity is stimulated by
expression of GTP-bound Cdc42 in vivo. This has not been
reported previously for S. cerevisiae; stimulation in vitro was
observed using baculovirus-produced proteins (58), but this
was not reproduced using Ste20 purified from yeast extracts
(27). Most importantly, we found that the signaling defect of
the S338A/H345G mutant correlated with an inability to re-
spond to Cdc42 stimulation, while the ability of L369G or
334–369 mutations to confer Cdc42-independent signaling
correlated with deregulated, Cdc42-independent kinase activ-
ity. Thus, our observations link the Cdc42 dependence of Ste20
kinase activity to the in vivo signaling behavior and argue that
signaling by wild-type Ste20 requires that its kinase activity be
stimulated by Cdc42.
How is Ste20 kinase activity harnessed by the mating path-
way? It is informative that, despite their hyperactive kinase
activity, the Cdc42-independent alleles 334–369, L369G, and
S338A/H345G/L369G do not show constitutive signaling—i.e.,
there is no increase in either the basal or induced levels of
FUS1-lacZ (Fig. 2C and data not shown; see also reference 27).
While this may appear counterintuitive, it is in fact consistent
with our previous arguments (39, 47) that the rate-limiting step
in pheromone signaling is unlikely to be the production of
active Ste20, but rather the access of Ste20 to its substrate—
namely, the MAP kinase kinase kinase Ste11 associated with
the scaffold protein Ste5 (18, 47)—perhaps along with other
events, such as conformational changes in Ste5 (54). Consis-
tent with this view, there is no indication that pheromone can
stimulate Ste20 kinase activity, as noted previously (65) and
confirmed here in parallel with experiments in which Ste20
kinase activity clearly could be stimulated by another method,
expression of Cdc42Q61L (Fig. 4B). The fact that pheromone
did not mimic Cdc42Q61L expression may also indicate that the
levels of GTP-bound Cdc42 are not increased by pheromone,
despite the known ability of G to assemble with the Cdc42
exchange factor, Cdc24. While association of G with Cdc24
helps guide cell polarization along pheromone gradients (11,
40, 41), it is unresolved whether G alters only the localiza-
tion or also the activity levels of Cdc24 and Cdc42, but cur-
rently there is no evidence for the latter.
It remains conceivable that pheromone effects on Cdc24,
Cdc42, and Ste20 activities do occur but are difficult to detect
because they either are extremely labile (e.g., GTP hydrolysis)
or involve only a small fraction of molecules. Nevertheless, it
seems clear that assembly of complexes involving G and
Cdc24 is not necessary for pheromone to induce Ste20-depen-
dent signaling, as mutants in which these complexes are dis-
rupted are fully competent at pheromone response (41). Fur-
thermore, we show here (Fig. 2B and 5C) that the effects of
disrupting the Cdc42-Ste20 interaction are apparent without
pheromone stimulation and in the absence of G (Ste4),
which, along with other observations (39, 47), suggests that the
Cdc42-dependent step normally precedes pathway activation
rather than requiring regulation by pheromone or G. There-
fore, in total these findings indicate that although both the
Cdc42-Ste20 interaction and Ste20 kinase activity are required
for pheromone-dependent signaling, pheromone stimulation
of these states is neither required nor evident.
The simplest model would seem to be that pheromone reg-
ulates the ability of an existing pool of active Ste20 to activate
the downstream MAP kinase cascade (Fig. 7). It is noteworthy
in this regard that overexpression of Ste20N, an “activated”
form of Ste20 lacking its N-terminal 495 residues, induces
FUS1-lacZ to relatively miniscule levels compared to the level
when pheromone is added (27); this suggests that pheromone
still triggers a critical rate-limiting event, such as phosphory-
lation of Ste11 by Ste20 (60, 65) or expedited signal transmis-
sion from activated Ste11 (18).
Related to the issue of how pathway stimuli harness Ste20
activity, our observations suggest that the role of the Cdc42-
Ste20 interaction is not qualitatively distinct between the mat-
ing and filamentation pathways, in contrast to previous con-
clusions (27, 45). Instead, we found that the two pathways are
impacted similarly by CRIB domain mutations: (i) precise dis-
ruption of the Cdc42-Ste20 interaction by point mutation
causes a severe reduction in function, and (ii) these defects are
suppressed by either the L369G point mutation or the com-
plete CRIB domain deletion, though not to wild-type efficacy
for either pathway. These observations indicate that both path-
ways require Cdc42 to bind Ste20 and that in each pathway a
primary role for this binding is to antagonize the negative effect
of the Ste20 CRIB domain (Fig. 7). In addition, when the
CRIB domain is completely removed from Ste20, producing a
hyperactive kinase, signaling in both pathways is not hyperac-
tive but instead is demonstrably less efficient (to a degree that
is exaggerated by reduced expression). It seems likely that this
handicap is due to delocalization from the plasma membrane,
where activation of the mating pathway MAP kinase cascade is
thought to be initiated (36, 47, 61). Whether activation of the
filamentation pathway MAP kinase cascade is also initiated at
the membrane is less clear, though interactions of Ste11 and
Ste7 kinases with the polarity proteins Spa2 and Sph1 (52, 56)
could potentially play a role in restricting filamentation path-
way signaling to the cell periphery. Proper localization is also
critical to the essential function shared by Ste20 and Cla4, as
removal of the Cdc42-binding site disrupts this function in
either kinase (6, 27, 45) (Fig. 5B). Relatedly, excess levels of
hyperactive Ste20 are lethal (27, 49) (Fig. 5A) and produce a
depolarized actin phenotype (27), similar to when Ste20 and
Cla4 are absent (22) or when Cdc42 is inactivated (1). This
requirement for not only PAK activity per se but also its proper
spatial regulation is consistent with the fundamental asymme-
try of cytoskeletal reorganization events regulated by Cdc42
during cell growth and division (23).
Although Ste20334–369 and Ste20S338A/H345G/L369G are de-
tectably impaired for signaling (e.g., in comparison to the
Ste20L369G form, which retains Cdc42-binding; cf. Fig. 2A ver-
sus 3A and see Fig. 5), it is somewhat surprising how well they
do signal, given their delocalization. It is conceivable that the
kinase hyperactivity of these forms compensates for their de-
localization to an extent that is purely coincidental. It is also
possible that these forms are still restricted to signaling in
specialized subcellular locales, in a manner assisted by inter-
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actions with other proteins. Indeed, the signaling efficiency of
Ste20334–369 appears to depend on interaction with the SH3
domain protein Bem1, as it is reduced by deletion of BEM1
(39) and by mutation of a Bem1-binding domain within Ste20
(M. J. Winters and P. M. Pryciak, unpublished data). This may
indicate that while Ste20334–369 is delocalized, it might still
signal predominantly at the cell periphery, where Bem1 is
abundant (3). Ste20 also binds the pheromone-activated G
complex (29), potentially allowing recruitment of Ste20 to its
mating pathway substrates in a manner that compensates to
some degree for defects in localization via Cdc42.
Further work will be required to determine the full spectrum
of mechanisms involved in colocalizing activated Ste20 with its
substrates and to describe the complete set of events triggered
by a specific pathway stimulus that are rate limiting for Ste20-
dependent signal transduction.
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